Current Issue - Q1 2019

The Business Development Issue

Rethinking the Ethical Corporate Vision

Our first quarter issue features leading insights from key opinion leaders on a variety of topics concerning business development in the pharma and biopharma outsourcing sector.

Download Issue

Also in This Issue

Nice Insight Overview

Pharma Tackles the Big Issues

Pharma Tackles the Big Issues, Nigel Walker, Nice Insight

Supply Chain Solutions

Integrated Clinical Packaging, Warehousing and Transport Services Supporting Pharma and Biopharma

Integrated Clinical Packaging, Warehousing and Transport Services Supporting Pharma and Biopharma, Gulam Jaffer, Yourway

Investment in Innovation

How Agile Investment Drives Innovation

How Agile Investment Drives Innovation, Thibaut Fraisse, Fareva

QPCR

Digital Droplet PCR for Viral Vector Analysis

Digital Droplet PCR for Viral Vector Analysis, Diego Matayoshi, Sushma Ogram Ph.D., Susan D’Costa Ph.D., Richard O. Snyder, Ph.D., Brammer Bio

Form-Fill-Seal

Investing in Form-Fill-Seal Technology

Investing in Form-Fill-Seal Technology, Lluc Mercadé, Grifols

Outsourcing

Aligning the Outsourcing Relationship

Aligning the Outsourcing Relationship, Gwenaël Servant Ph.D., Servier

Viral Vectors

Preclinical to Nearly Commercial Virus and Viral Vector Manufacturing

Preclinical to Nearly Commercial Virus and Viral Vector Manufacturing, Jean Bléhaut, Novasep

Commercialization

Adjusting Internal Structure to Better Meet Demands of Unmet Business

Adjusting Internal Structure to Better Meet Demands of Unmet Business, James E. Gregory, UPM Pharmaceuticals

HPAPI

Investing in the Future of Potent Compounds

Investing in the Future of Potent Compounds, Frederic Desdouits, Seqens

Engineering

Leveraging Operational Simulations to Design Cell Therapy Facilities

Leveraging Operational Simulations to Design Cell Therapy Facilities, Niranjan Kulkarni, CRB USA

CPhI & P-MEC China

A World of Opportunity: What to Expect from CPhI & P-MEC China

A World of Opportunity: What to Expect from CPhI & P-MEC China

Cell and Gene Therapy

Driving Growth of the Cell and Gene Therapy Sector

Driving Growth of the Cell and Gene Therapy Sector, Felix Hsu, WuXi Advanced Therapies

Formulation

Developing and Characterizing DPI Formulations for Biologics

Developing and Characterizing DPI Formulations for Biologics, Constança Cacela Ph.D., Eunice Costa Ph.D., Hovione

Drug Pricing

Balancing Ethical and Fiduciary Responsibilities in Drug Pricing

Evolving Business Models and an Ethical Paradigm Shift, Balancing Ethical and Fiduciary Responsibilities in Drug Pricing, David Alvaro, Ph.D., Cynthia Challener, Ph.D., Emilie Branch, Nice Insight

Clinical Trials

Evolving Ethical Conduct Concerns in Clinical Trials

Evolving Business Models and an Ethical Paradigm Shift, Evolving Ethical Conduct Concerns in Clinical Trials, David Alvaro, Ph.D., Cynthia Challener, Ph.D., Emilie Branch, Nice Insight

Virtual Panel

Reprioritizing to Bring FY2020 into Focus

Reprioritizing to Bring FY2020 into Focus, Jeanne Thoma, Sarath Chandar, Graeme Macleod, Jon Struthers, Joe Rogus, Coralyn Gonzalez, John Creighton, SPI Pharma

Benefitting U.S. Clients

Rentschler Biopharma SE Sets Foot in the  U.S. to Strengthen its World-Class CDMO Position

Rentschler Biopharma SE Sets Foot in the  U.S. to Strengthen its World-Class CDMO Position, Federico Pollano, Rentschler Biopharma SE

Attracting Investment

Preparing Middle-Market Firms to Attract Investment

Preparing Middle-Market Firms to Attract Investment, Jeffrey Marlough, Castleford Capital

Facility Sales

Setting Expectations for Facility and Business Sales in the CDMO Sector

Setting Expectations for Facility and Business Sales in the CDMO Sector, William B. Wiederseim, PharmaBioSource

Meet the Investor

Selecting the Right Private Equity Partner to Build a Leading Outsourcing Provider

Selecting the Right Private Equity Partner to Build a Leading Outsourcing Provider, David Q. Anderson, Ampersand Capital Partners

Q of E

Quality of Earnings: The Most Important Term You Probably Don’t Know

Quality of Earnings: The Most Important Term You Probably Don’t Know, Michael Geldart, Eric Mattson, Excellere Partners

Consolidation

Factors Driving Consolidation in the CDMO Space

Factors Driving Consolidation in the CDMO Space, Jason Foss, Results Healthcare

Leveraging Expertise

Similar, Different and Constantly Varied

Similar, Different and Constantly Varied, Steve King, 21159Pharma

The U.K. Market

U.K. Healthcare Firms Creating Value Worldwide

U.K. Healthcare  Firms Creating Value Worldwide, Hemavli Bali, Clearwater International Corporate Finance

Risk Management

The Value Triangle: Risk Management for RMATs

The Value Triangle: Risk Management for RMATs, John Wass, CAI Commissioning Agents Inc.

Generics

Finding the Right Product Platform: A Personal Perspective

Finding the Right Product Platform: A Personal Perspective, Ori Gutwerg

Global Partner

A World-Class Partner for Today’s Market

A World-Class Partner for Today’s Market, Oliver Ju, Porton Pharma Solutions

Lifecycle Support

Speed and Customized Support from Gene to GMP Manufacturing

Speed and Customized Support from Gene to GMP Manufacturing, Giedrius Žunda, Biotechpharma

Artificial Intelligence

Pharma Makes Moves to Leverage Artificial Intelligence

Pharma Makes Moves to Leverage Artificial Intelligence, Cynthia A. Challener, Ph.D., Nice Insight

Process Development

Overcoming Challenges in Microbial Process Development

Overcoming Challenges in Microbial Process Development, Elise Mous, Capua Bioservices

Continuous Manufacturing

Twin-Screw Melt Granulation as a Platform Technology for Continuous Manufacturing

Twin-Screw Melt Granulation as a Platform Technology for Continuous Manufacturing, Tony Listro, Foster Delivery Science

Biosimilars

Accelerating Biosimilar Development

Accelerating Biosimilar Development, John Gabrielson, KBI Biopharma

Clinical Trial Logistics

Facilitating Complex Clinical Trials For Rare Diseases

Facilitating Complex Clinical Trials For Rare Diseases, Ariette van Strien, Marken, Clinical Trial Logistics

Fill/Finish

Fill/Finish: Increasing Investment and Flexibility for Effective Manufacturing

Fill/Finish: Increasing Investment and Flexibility for Effective Manufacturing, B.J. Hull, Emergent BioSolutions

The Ideal Capsule Supplier: Using A Holistic Approach to Facilitate Customer Success

The Ideal Capsule Supplier: Using A Holistic Approach to Facilitate Customer Success, Jonathan Gilinski, CapsCanada

Drug Discovery

A Research Partner With Proven Results

A Research Partner With Proven Results, Daniel Conlon, IRBM

Comparator Drugs

Addressing the Challenges of Comparator Drug Sourcing for Clinical Trials

Addressing the Challenges of Comparator Drug Sourcing for Clinical Trials, Salman Pathan, Globyz Pharm

Generics Manufacturing

Generics Manufacturing and Changing Equipment Needs

Generics Manufacturing and Changing Equipment Needs, Justin Kadis, Federal Equipment Company

Small Molecule API

Supporting Client Projects for CDMO Success

Supporting Client Projects for CDMO Success, Marc Sauer Ph.D., Mark Wellman, BioVectra

Process Development

Process Understanding Central to Successful Drug Synthesis

Process Understanding Central to Successful Drug Synthesis, James J. Springer, Robert Hughes, Albemarle Fine Chemistry Services

Formulated Solutions: Redefining the Consumer Healthcare Experience

Formulated Solutions: Redefining the Consumer Healthcare Experience, Design Logic, Formulated Solutions Website Launch

Year in Review

Pharma’s Almanac Most Impactful Thought Leadership of 2018

Pharma’s Almanac Most Impactful Thought Leadership of 2018, Nice Insight

Immunotherapy

Collaborating for Immunotherapy Development

Collaborating for Immunotherapy Development, KshitiJ (TJ) Ladage, Nice Insight

Workplace Culture

Award-Winning Performance Driven by an Award-Winning Workplace Culture

Award-Winning Performance Driven by an Award-Winning Workplace Culture, Peter Pekos, Dalton Pharma Services

Antibody-Drug Conjugates

Rapid Growth in the ADC Market Drives Strategic Partnership Interest

Rapid Growth in the ADC Market Drives Strategic Partnership Interest, Allan Davidson, Piramal Pharma Solutions

Regulatory Spotlight

Understanding the FDA’s Approach to Real-World Evidence

Understanding the FDA’s Approach to Real-World Evidence, David Alvaro, Ph.D., Nice Insight

Ethical Business Practices

Q: Given the ongoing evolution of the pharma industry today, how does your organization incorporate ethical concerns into your business practices?

Roundtable, Olivier Loeillot, GE Healthcare, Franco Negron, Thermo Fisher Scientific, Ed Price, PCI Synthesis, Shannon Trilli, Catalent, Jessica Martin, SGS Life Science Services

Artificial Intelligence

Q: What do you believe the role of artificial intelligence and other advanced technologies will be in driving the development of the pharmaceutical industry over the next decade?

Roundtable, Franco Negron, Thermo Fisher Scientific, Andreas Persidis, Ph.D., Biovista, Ben Newton, GE Healthcare, Ed Price, PCI Synthesis

2018

Issue Q4 2018

The Innovation Issue

View Issue »
Issue #4 | Volume #4 | Q4 2018
Issue Q3 2018

The Outsourcing Issue

View Issue »
Issue #3 | Volume #4 | Q3 2018
Issue Q2 2018

The Next-Generation Issue

View Issue »
Issue #2 | Volume #4 | Q2 2018
Issue Q1 2018

The Executive Issue

View Issue »
Issue #1 | Volume #4 | Q1 2018